Sacramento, CALIFORNIA10 Active Studies

Essential Tremor Clinical Trials in Sacramento, CALIFORNIA

Find 10 actively recruiting essential tremor clinical trials in Sacramento, CALIFORNIA. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
4,784
Enrolling

Recruiting Essential Tremor Studies in Sacramento

RecruitingSacramento, CALIFORNIANCT06628908

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

1,100 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingSacramento, CALIFORNIANCT06957080

A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, ranibizumab, in patients with diabetic ma...

960 participants
EyeBiotech Ltd.
View Study Details
RecruitingSacramento, CALIFORNIANCT04262466

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell receptor against cancer (ImmTAC ®) designed for the treatment of cancers positive for the tumor-associated antigen PRAME. This is a fi...

727 participants
Immunocore Ltd
View Study Details
RecruitingSacramento, CALIFORNIANCT04661358

Fenofibrate for Prevention of DR Worsening

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately s...

560 participants
Jaeb Center for Health Research
View Study Details
RecruitingSacramento, CALIFORNIANCT06850922

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME). The study consists of 2 segments: Phase I (Parts 1...

546 participants
Genentech, Inc.
View Study Details
RecruitingSacramento, CALIFORNIANCT05640999

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

This protocol tests de-escalated adjuvant treatment in patients with POLE-mutated or p53wt/NSMP (p53 wildtype/no specific molecular profile) early-stage endometrial cancer (EC). Patients may be enroll...

393 participants
Canadian Cancer Trials Group
View Study Details
RecruitingSacramento, CALIFORNIANCT06840496

To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

Primary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo in girls and women with Rett syndrome Key Secondary Objective • To investigate the efficacy of treatme...

210 participants
Biomed Industries, Inc.
View Study Details
RecruitingSacramento, CALIFORNIANCT06321302

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...

178 participants
Boehringer Ingelheim
View Study Details
RecruitingSacramento, CALIFORNIANCT04634578

Bevacizumab Treatment For Type 1 ROP

Type 1 retinopathy of prematurity in zone I represents the most severe type of ROP and has the worst prognosis. It is unknown whether low-dose bevacizumab will be successful in these severe cases. Als...

80 participants
Jaeb Center for Health Research
View Study Details
RecruitingSacramento, CALIFORNIANCT05691465

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

This phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places in the body (metastati...

30 participants
National Cancer Institute (NCI)
View Study Details

About Essential Tremor Clinical Trials in Sacramento

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 10 essential tremor clinical trials recruiting participants in Sacramento, CALIFORNIA. These studies are seeking a combined 4,784 participants. Research is being sponsored by Vertex Pharmaceuticals Incorporated, EyeBiotech Ltd., Immunocore Ltd and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Sacramento — FAQ

Are there essential tremor clinical trials in Sacramento?

Yes, there are 10 essential tremor clinical trials currently recruiting in Sacramento, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 10 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated March 2, 2026 from ClinicalTrials.gov